ZeroStack (ZSTK) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
8 May, 2026Executive summary
Annual and Special Meeting scheduled for July 13, 2026, to address key proposals including director elections, auditor re-appointment, equity issuances, compensation plans, and corporate jurisdiction change.
Shareholders can vote in person, by proxy, or online, with detailed instructions provided for each method.
Board recommends voting in favor of all proposals, emphasizing alignment with shareholder interests and long-term growth.
Voting matters and shareholder proposals
Proposals include electing five directors, re-appointing Davidson & Company LLP as auditors, approving a PIPE offering issuance, amending the 2022 Incentive Compensation Plan, granting executive stock options, authorizing continuance to Texas, classifying the board, and potential adjournments.
Each proposal requires a simple majority, except the continuance to Texas, which needs two-thirds approval.
Shareholders may submit proposals for the 2027 meeting by February 3, 2027.
Board of directors and corporate governance
Board consists of five directors, with a mix of executive and independent members.
Proposal to classify the board into three staggered classes for continuity and anti-takeover protection.
Committees include Audit, Compensation, and Nominating and Corporate Governance, all with independent directors.
Code of Conduct and Ethics applies to all directors, officers, and employees.
Latest events from ZeroStack
- Q1 2026 saw higher revenue but a $36.7M net loss due to digital asset fair value declines.ZSTK
Q1 20264 May 2026 - Net loss surged to $119.7M on digital asset losses as the company pivoted to an AI-focused treasury model.ZSTK
Q4 202527 Feb 2026 - Net loss narrowed to $2.7M as revenue fell and global expansion, cost cuts, and new launches continued.ZSTK
Q2 20242 Feb 2026 - Q3 revenue dropped and net loss widened, but U.S. and German growth prospects remain.ZSTK
Q3 202414 Jan 2026 - Strategic shift to AI and digital assets, with major OG Token holdings and expanded pharma reach.ZSTK
Registration Filing8 Jan 2026 - Registering 3.86M shares for resale; proceeds go to investors, not the company.ZSTK
Registration Filing16 Dec 2025 - 3.2 million shares registered for resale after acquisition and executive grants; no proceeds to issuer.ZSTK
Registration Filing16 Dec 2025 - 3.2 million shares registered for resale; no proceeds to company; global cannabis expansion focus.ZSTK
Registration Filing16 Dec 2025 - Shareholders to vote on TruHC acquisition, equity plan, and executive awards amid ongoing losses.ZSTK
Proxy Filing2 Dec 2025